vs
Side-by-side financial comparison of Good Times Restaurants Inc. (GTIM) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $32.7M, roughly 1.2× Good Times Restaurants Inc.). Good Times Restaurants Inc. runs the higher net margin — 0.6% vs -161.8%, a 162.4% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -10.0%). Good Times Restaurants Inc. produced more free cash flow last quarter ($1.2M vs $-71.3M).
Good Times is a Golden, Colorado–based fast-food restaurant specializing in premium burgers and frozen custard. As of July 2023, the chain operates 31 locations, down from 38 in 2015.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
GTIM vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.7M | $38.3M |
| Net Profit | $181.0K | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 0.9% | -169.0% |
| Net Margin | 0.6% | -161.8% |
| Revenue YoY | -10.0% | 407.0% |
| Net Profit YoY | 10.4% | -4.7% |
| EPS (diluted) | $0.02 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.7M | $38.3M | ||
| Q3 25 | $37.0M | $32.1M | ||
| Q2 25 | $34.3M | $26.4M | ||
| Q1 25 | — | $16.5M | ||
| Q4 24 | $36.3M | $7.6M | ||
| Q3 24 | $35.8M | $6.1M | ||
| Q2 24 | $38.0M | — | ||
| Q1 24 | $35.4M | — |
| Q4 25 | $181.0K | $-61.9M | ||
| Q3 25 | $1.5M | $-67.3M | ||
| Q2 25 | $-624.0K | $-92.6M | ||
| Q1 25 | — | $-129.6M | ||
| Q4 24 | $164.0K | $-59.2M | ||
| Q3 24 | $230.0K | $-85.7M | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $618.0K | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.9% | -169.0% | ||
| Q3 25 | 3.3% | -173.5% | ||
| Q2 25 | -1.5% | -269.8% | ||
| Q1 25 | — | -390.1% | ||
| Q4 24 | 0.2% | -919.0% | ||
| Q3 24 | -0.3% | -1314.3% | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 0.6% | -161.8% | ||
| Q3 25 | 4.0% | -209.8% | ||
| Q2 25 | -1.8% | -350.3% | ||
| Q1 25 | — | -784.9% | ||
| Q4 24 | 0.5% | -783.4% | ||
| Q3 24 | 0.6% | -1404.0% | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | $0.02 | $-0.06 | ||
| Q3 25 | $0.14 | $-0.07 | ||
| Q2 25 | $-0.06 | $-0.10 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | $0.02 | $-0.08 | ||
| Q3 24 | $0.01 | $-0.14 | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $33.2M | $-500.5M |
| Total Assets | $82.5M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $242.8M | ||
| Q3 25 | — | $257.8M | ||
| Q2 25 | $2.7M | $153.7M | ||
| Q1 25 | — | $61.6M | ||
| Q4 24 | $3.0M | $149.8M | ||
| Q3 24 | $3.9M | $130.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | $4.0M | — |
| Q4 25 | $33.2M | $-500.5M | ||
| Q3 25 | $33.1M | $-524.3M | ||
| Q2 25 | $31.6M | $-570.7M | ||
| Q1 25 | — | $-591.4M | ||
| Q4 24 | $32.4M | $-489.1M | ||
| Q3 24 | $32.4M | $-745.1M | ||
| Q2 24 | $32.3M | — | ||
| Q1 24 | $31.6M | — |
| Q4 25 | $82.5M | $501.9M | ||
| Q3 25 | $85.8M | $519.0M | ||
| Q2 25 | $86.9M | $402.1M | ||
| Q1 25 | — | $303.8M | ||
| Q4 24 | $89.5M | $382.9M | ||
| Q3 24 | $87.1M | $364.6M | ||
| Q2 24 | $90.1M | — | ||
| Q1 24 | $89.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $-70.4M |
| Free Cash FlowOCF − Capex | $1.2M | $-71.3M |
| FCF MarginFCF / Revenue | 3.8% | -186.2% |
| Capex IntensityCapex / Revenue | 0.6% | 2.4% |
| Cash ConversionOCF / Net Profit | 7.85× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-72.0K | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $-70.4M | ||
| Q3 25 | $1.3M | $-68.9M | ||
| Q2 25 | $714.0K | $-79.7M | ||
| Q1 25 | — | $-85.9M | ||
| Q4 24 | $-518.0K | $-85.1M | ||
| Q3 24 | $394.0K | $-98.8M | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | $1.8M | — |
| Q4 25 | $1.2M | $-71.3M | ||
| Q3 25 | $735.0K | $-69.6M | ||
| Q2 25 | $-105.0K | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | $-1.9M | $-87.3M | ||
| Q3 24 | $-466.0K | $-101.6M | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $1.2M | — |
| Q4 25 | 3.8% | -186.2% | ||
| Q3 25 | 2.0% | -217.2% | ||
| Q2 25 | -0.3% | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | -5.3% | -1155.4% | ||
| Q3 24 | -1.3% | -1663.2% | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 0.6% | 2.4% | ||
| Q3 25 | 1.4% | 2.3% | ||
| Q2 25 | 2.4% | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 3.9% | 28.0% | ||
| Q3 24 | 2.4% | 45.7% | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | 7.85× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.16× | — | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 2.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
